{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:57:25Z","timestamp":1791482245006,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["australiancriticalcare.com","clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Australian Critical Care"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.aucc.2026.101691","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:52:52Z","timestamp":1791402772000},"page":"101691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vancomycin dosing and monitoring in the intensive care unit: Guideline adherence and efficacy"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3816-0849","authenticated-orcid":false,"given":"Robin","family":"Curran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3377-6062","authenticated-orcid":false,"given":"Krishnaswamy","family":"Sundararajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8615-6109","authenticated-orcid":false,"given":"Michael","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1253-8700","authenticated-orcid":false,"given":"Philip","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mardi","family":"Wills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aucc.2026.101691_bib1","unstructured":"Guidelines T. Home | Therapeutic Guidelines [Internet]. [cited 2025 Apr 10]. Available from: https:\/\/www.tg.org.au\/."},{"issue":"6","key":"10.1016\/j.aucc.2026.101691_bib2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.aucc.2026.101691_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4103\/ijmm.IJMM_17_278","article-title":"Optimisation of antimicrobial dosing based on pharmacokinetic and pharmacodynamic principles","volume":"35","author":"Hoo","year":"2017","journal-title":"Indian J Med Microbiol"},{"issue":"3","key":"10.1016\/j.aucc.2026.101691_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/phar.2231","article-title":"Augmented renal clearance","volume":"39","author":"Cook","year":"2019","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"issue":"3","key":"10.1016\/j.aucc.2026.101691_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/2042018816638223","article-title":"Review of vancomycin-induced renal toxicity: an update","volume":"7","author":"Bamgbola","year":"2016","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.aucc.2026.101691_bib6","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2215\/CJN.05920616","article-title":"Vancomycin and the risk of AKI: a systematic review and meta-analysis","volume":"11","author":"Sinha Ray","year":"2016","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"5","key":"10.1016\/j.aucc.2026.101691_bib7","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jcrc.2013.01.004","article-title":"Evaluation of a vancomycin dosing nomogram based on the Modification of Diet in Renal Disease equation in intensive care unit patients","volume":"28","author":"Golenia","year":"2013","journal-title":"J Crit Care"},{"issue":"11","key":"10.1016\/j.aucc.2026.101691_bib8","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1093\/jac\/dkab278","article-title":"Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients","volume":"76","author":"Hodiamont","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.aucc.2026.101691_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"10.1016\/j.aucc.2026.101691_bib10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/aas.12897","article-title":"Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study","volume":"61","author":"Bakke","year":"2017","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"10.1016\/j.aucc.2026.101691_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.aucc.2026.101691_bib12","series-title":"R: A Language and Environment for Statistical Computing} [Internet]","year":"2024"},{"key":"10.1016\/j.aucc.2026.101691_bib13","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"key":"10.1016\/j.aucc.2026.101691_bib14","series-title":"epitools: Epidemiology Tools (R package version 0.5-10.1) [R] [Internet]","author":"Argon","year":"2020"},{"issue":"3","key":"10.1016\/j.aucc.2026.101691_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/cc13874","article-title":"Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study","volume":"18","author":"Blot","year":"2014","journal-title":"Crit Care Lond Engl"},{"issue":"11","key":"10.1016\/j.aucc.2026.101691_bib16","first-page":"e804","article-title":"Evaluation of a vancomycin dosing nomogram in achieving high target trough concentrations in Taiwanese patients","volume":"16","author":"Leu","year":"2012","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"issue":"5","key":"10.1016\/j.aucc.2026.101691_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1592\/phco.31.5.441","article-title":"Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg\/L suggested by the vancomycin consensus guidelines","volume":"31","author":"Kullar","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.aucc.2026.101691_bib18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00228-016-2063-8","article-title":"Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons","volume":"72","author":"Elyasi","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.aucc.2026.101691_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jinf.2022.06.029","article-title":"Assessment of an institutional guideline for vancomycin dosing and identification of predictive factors associated with dose and drug trough levels","volume":"85","author":"Gu","year":"2022","journal-title":"J Infect"}],"container-title":["Australian Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S103673142600161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S103673142600161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:39:16Z","timestamp":1791481156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S103673142600161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S103673142600161X"],"URL":"https:\/\/doi.org\/10.1016\/j.aucc.2026.101691","relation":{},"ISSN":["1036-7314"],"issn-type":[{"value":"1036-7314","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vancomycin dosing and monitoring in the intensive care unit: Guideline adherence and efficacy","name":"articletitle","label":"Article Title"},{"value":"Australian Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aucc.2026.101691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101691"}}